| Technology, AI, semiconductors, cloud computing, consumer electronics, social media, app ecosystems, e-commerce, military technology, energy independence, venture capital, unicorns and scaling, banking innovation, space exploration, biotech and pharma... |
| |
| ▲ | rafaelmn 5 days ago | parent | next [-] | | Down 2/3 in a year because it failed to capitalize on an early score compared to US competition. Not saying EU has no companies just that they get left behind by competition. On the industry side its falling behind to Asia, finance and tech is losing to US. The only thing growing is luxury brands - kind of ironic that the only thing EU does well is selling pretentiousness. | |
| ▲ | cooper_ganglia 5 days ago | parent | prev [-] | | Novo is a success story, sure, but it's not uniquely dominant. Eli Lilly is more than 3x bigger in the same space, and J&J, Merck, Pfizer all rival or surpass it. Pharma as a whole is still dwarfed by the trillion-dollar US tech giants that the EU has no equivalent of. One standout doesn't change the broader lag. |
|
